Publications by authors named "Francesca Colonese"

Claim this Profile
B
Bone metastases in NSCLC: Modern paradigms in management and supportive care.
Gabriele Minuti, Giorgia Pasqualini, Alice Avancini, Niccolò Giaj-Levra, Francesca Colonese

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Chemo/Immunotherapies in Lung Cancer: A Critical Review on the Value of Perioperative Sequences.
Thoma' Dario Clementi, Francesca Colonese, Stefania Canova, Maria Ida Abbate, Luca Sala

Curr Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current diagnostic and therapeutical approaches to bone metastases in patients with non-small cell lung cancer: A cross-sectional study.
Alice Avancini, Niccolò Giaj-Levra, Gabriele Minuti, Giorgia Pasqualini, Francesca Colonese

Lung Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer.
Gaia Passarella, Stefania Canova, Maria Ida Abbate, Giulia Caspani, Luca Sala, Francesca Colonese

Discov Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral Treatment in Lung Cancer: Is It Time to Move Towards Clinical Practice?
Gabriele Giuseppe Pagliari, Francesca Colonese, Stefania Canova, Maria Ida Abbate, Luca Sala

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in Non-Small-Cell Lung Cancer: A Modified Delphi Survey Consensus on First Line Treatment, Special Populations and Rechallenge.
Francesca Colonese, Alessandra Bulotta, Carlo Genova, Diego Signorelli, Laura Bonanno

Biomedicines· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer.
Nicoletta Cordani, Daniele Nova, Luca Sala, Maria Ida Abbate, Francesca Colonese

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach.
Giovanni Luca Ceresoli, Giulio Rossi, Francesco Agustoni, Lucia Bonomi, Paolo Borghetti, Francesca Colonese

Crit Rev Oncol Hematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Therapeutic Options for Small Cell Lung Cancer.
Stefania Canova, Benedetta Trevisan, Maria Ida Abbate, Francesca Colonese, Luca Sala

Curr Oncol Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-rate breakthrough cancer pain and tumour characteristics - literature review and case series.
Arturo Cuomo, Anastasios Boutis, Francesca Colonese, Davide Nocerino

Drugs Context· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
Carlo Putzu, Stefania Canova, Panagiotis Paliogiannis, Renato Lobrano, Luca Sala, Francesca Colonese

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons.
Diego Luigi Cortinovis, Francesca Colonese, Maria Ida Abbate, Luca Sala, Marco Meazza Prina

Front Med (Lausanne)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature.
Maria Gemelli, Marco Carbone, Maria I Abbate, Maddalena Mancin, Nicola Zucchini, Francesca Colonese

Immunotherapy· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti PD-L1 antibody: is there a histologic-oriented efficacy? Focus on atezolizumab in squamous cell non-small cell lung cancer.
Maria Gemelli, Paolo Bidoli, Francesca Colonese, Stefania Canova, Diego Cortinovis

Front Biosci (Schol Ed)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma.
Diego Cortinovis, Paolo Bidoli, Stefania Canova, Francesca Colonese, Maria Gemelli

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases.
Diego Cortinovis, Rita Chiari, Annamaria Catino, Francesco Grossi, Filippo DE Marinis, Francesca Colonese

Anticancer Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review.
Maria Ida Abbate, Diego Luigi Cortinovis, Marcello Tiseo, Tiziana Vavalà, Giulio Cerea, Francesca Colonese

Future Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab.
Carlo Putzu, Diego Luigi Cortinovis, Francesca Colonese, Stefania Canova, Ciriaco Carru

Cancer Immunol Immunother· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in ALK inhibition of ALK-positive non-small-cell lung cancer: from ALK positivity detection to treatment strategies after relapse.
Diego Cortinovis, Stefania Canova, Maria I Abbate, Francesca Colonese, Viola Cogliati

Future Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection.
Giuseppe Luigi Banna, Francesco Passiglia, Francesca Colonese, Stefania Canova, Jessica Menis

Crit Rev Oncol Hematol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new race against lung cancer.
Diego Cortinovis, Stefania Canova, Mariaida I Abbate, Francesca Colonese, Paolo Bidoli

J Vis Surg· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "Is there a role for vitamin D in human reproduction?".
Francesca Colonese, Valentina Lucia La Rosa, Antonio Simone Laganà, Salvatore Giovanni Vitale, Diego Cortinovis

Horm Mol Biol Clin Investig· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focus on Nivolumab in NSCLC.
Diego L Cortinovis, Stefania Canova, Marida Abbate, Francesca Colonese, Paolo Bidoli

Front Med (Lausanne)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pleiotropic effects of vitamin D in gynaecological and obstetric diseases: an overview on a hot topic.
Francesca Colonese, Antonio Simone Laganà, Elisabetta Colonese, Vincenza Sofo, Francesca Maria Salmeri

Biomed Res Int· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis